NCT03253562View on ClinicalTrials.gov

Metformin Versus Vildagliptin for Diabetic Hypertensive Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 1, 2017

Primary Completion Date

August 1, 2017

Study Completion Date

August 1, 2017

Conditions
Reducing the Elevated Blood Pressure for Diabetic Hypertensive Patients
Interventions
DRUG

Metformin Pill

a biguanide used as an insulin sensitizer for patients suffering from type 2 diabetes mellitus

DRUG

Vildagliptin 50 mg

Dpp4i antihyperglycemic drug used for treatment of type 2 diabetes mellitus

Trial Locations (1)

11311

National institute of diabetes and endocrinology, Cairo

All Listed Sponsors
lead

MTI University

OTHER

NCT03253562 - Metformin Versus Vildagliptin for Diabetic Hypertensive Patients | Biotech Hunter | Biotech Hunter